,Query,Gene,serum_mlt.ft.logFC.xBirA.Cre.over.NoBirA,serum_mlt.ft.adj.P.Val.xBirA.Cre.over.NoBirA,serum_mlt.ft.cellular_component,serum_mlt.ft.biological_process,serum_mlt.ft.molecular_function,Signal,SignalType,Start,End,ConfNuc,ConfFam,AnnotationType,Origin,Added,Modified
1,A0A1D5RLM8,Gm11639,4.812166667,0.000293415,,,,KRKRKS,NLS,5797,5802,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
2,A0A1D5RLM8,Gm11639,4.812166667,0.000293415,,,,HKRDK,NLS,5397,5401,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
3,A0A1D5RLM8,Gm11639,4.812166667,0.000293415,,,,KSNKR,NLS,1442,1446,5,5,Potential,In Silico Mutagenesis,10/11/17,10/11/17
4,A2AFG3,Pdzd4,5.022,0.000164821,,protein ubiquitination|,ubiquitin protein ligase activity|,VMLQE,NES,17,21,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
5,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,GRVRKL,NLS,14125,14130,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
6,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,KKERNS,NLS,29584,29589,3,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
7,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,KRDAER,NLS,21614,21619,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
8,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,KSKKKSK,NLS,34019,34025,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
9,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,KSRKKD,NLS,2025,2030,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
10,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,SKRRKT,NLS,11582,11587,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
11,A2ASS6,Ttn,6.083666667,0.003717029,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,LVLENK,NES,31996,32001,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
12,D3YYQ8,Dnah10,5.114666667,0.000148189,inner dynein arm|,cilium movement|metabolic process|,microtubule motor activity|ATP binding|ATPase activity|,RKLPRQ,NLS,1426,1431,1,1,By Expert,P03256,10/11/17,10/11/17
13,E9PUU4,Gemin5,4.719333333,0.000167312,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,KPKLKK,NLS,738,743,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
14,E9PUU4,Gemin5,4.719333333,0.000167312,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,LKKKKKP,NLS,741,747,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
15,E9PZ26,Brd1,4.693333333,0.000145021,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,TKRHK,NLS,89,93,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
16,E9PZ26,Brd1,4.693333333,0.000145021,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,QPRKR,NLS,796,800,8,6,Potential,In Silico Mutagenesis,10/11/17,10/11/17
17,E9PZ26,Brd1,4.693333333,0.000145021,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,PRKRSR,NLS,797,802,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
18,E9Q616,Ahnak,4.989666667,0.000156464,nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,KFKKP,NLS,4754,4758,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
19,F6VAN0,Atf6,4.439666667,0.000156464,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|integral component of endoplasmic reticulum membrane|,"transcription, DNA-templated|endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|cAMP response element binding|protein heterodimerization activity|,PSPKRR,NLS,359,364,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
20,F6ZDS4,Tpr,5.123833333,0.000145021,kinetochore|nucleus|nuclear envelope|nuclear pore|cytoplasm|cytoplasmic dynein complex|extrinsic component of membrane|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|mitotic spindle|kinetochore|,negative regulation of transcription from RNA polymerase II promoter|MAPK import into nucleus|RNA import into nucleus|RNA export from nucleus|nuclear pore organization|mitotic nuclear division|mitotic spindle assembly checkpoint|regulation of mitotic sister chromatid separation|positive regulation of heterochromatin assembly|mRNA export from nucleus in response to heat stress|cellular response to heat|cellular response to interferon-alpha|positive regulation of protein import into nucleus|negative regulation of translational initiation|positive regulation of protein export from nucleus|negative regulation of RNA export from nucleus|cell division|response to epidermal growth factor|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of intracellular protein transport|regulation of mitotic spindle assembly|protein import into nucleus|protein export from nucleus|nuclear pore organization|regulation of protein stability|regulation of protein import into nucleus|nuclear matrix organization|nuclear pore complex assembly|,chromatin binding|mRNA binding|nucleocytoplasmic transporter activity|protein binding|tubulin binding|heat shock protein binding|protein homodimerization activity|poly(A) RNA binding|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein anchor|,TKRKG,NLS,437,441,9,6,Potential,In Silico Mutagenesis,10/11/17,10/11/17
21,F8VQL9,Ncor2,5.478166667,0.000357489,histone deacetylase complex|nucleus|nucleoplasm|membrane|nuclear matrix|nuclear body|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|heart morphogenesis|telencephalon development|cell proliferation in forebrain|forebrain development|glucose homeostasis|negative regulation of fat cell differentiation|negative regulation of transcription, DNA-templated|white fat cell differentiation|Type I pneumocyte differentiation|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter|positive regulation of protein deacetylation|",DNA binding|chromatin binding|transcription corepressor activity|Notch binding|protein binding|histone deacetylase binding|sequence-specific DNA binding|protein N-terminus binding|,FKRRN,NLS,284,288,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
22,P49452,Cenpc,4.416166667,0.000158712,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,KRKSKS,NLS,240,245,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
23,P49452,Cenpc,4.416166667,0.000158712,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,ETVKRK,NLS,237,242,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
24,P49452,Cenpc,4.416166667,0.000158712,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,GKVNKK,NLS,752,757,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
25,Q3U9N4,Grn,4.444,0.00045897,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,PGPRRR,NLS,6,11,3,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
26,Q5I012,Slc38a10,4.518,0.001465541,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,KRRTY,NLS,65,69,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
27,Q60805,Mertk,4.993333333,0.000614446,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,PWILA,NES,367,371,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
28,Q6T5E4,Gcnt2,4.933666667,0.001318297,membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",ISVLAE,NES,40,45,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
29,Q80T79,Csmd3,5.009166667,0.000261034,plasma membrane|integral component of membrane|,,,TKRKG,NLS,1944,1948,9,6,Potential,In Silico Mutagenesis,10/11/17,10/11/17
30,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,PKQKRH,NLS,2527,2532,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
31,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,RRGRRR,NLS,2430,2435,6,6,Potential,In Silico Mutagenesis,10/11/17,10/11/17
32,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,RRMKSK,NLS,567,572,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
33,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,KRHRC,NLS,2530,2534,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
34,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,LIHKR,NLS,1217,1221,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
35,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,RGRKGK,NLS,1579,1584,7,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
36,Q8BYH8,Chd9,4.6305,0.000158712,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,RGRRPK,NLS,2620,2625,5,5,Potential,In Silico Mutagenesis,10/11/17,10/11/17
37,Q8CB77,Eloa,4.494,0.00029264,extracellular space|nucleus|cytoplasm|integral component of membrane|elongin complex|,regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,DNA binding|ubiquitin-protein transferase activity|,RPRKVP,NLS,470,475,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
38,Q8K0D2,Habp2,4.520333333,0.000558561,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,SRHRRR,NLS,164,169,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
39,Q9CR42,Ankrd1,4.755666667,0.001806964,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,KKRKKY,NLS,94,99,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
40,Q9CR42,Ankrd1,4.755666667,0.001806964,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,LKKRKK,NLS,93,98,4,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
41,Q9CR42,Ankrd1,4.755666667,0.001806964,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,RKKYKK,NLS,96,101,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
42,Q9WUF3,Casp8ap2,4.596,0.000944378,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,IFKSLL,NES,1295,1300,2,2,Potential,In Silico Mutagenesis,10/11/17,10/11/17
43,Q9WUF3,Casp8ap2,4.596,0.000944378,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,KRHDG,NLS,715,719,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17
44,Q9WUF3,Casp8ap2,4.596,0.000944378,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,HKDTK,NLS,494,498,3,3,Potential,In Silico Mutagenesis,10/11/17,10/11/17